Mart Maasik

General Partner at Nordic Science Investments, an early-stage venture capital fund investing in research-driven spinouts across the Nordics and Baltics.

Over 20 years of experience in finance, business development and innovation, including co-founding and leading SEB Group’s Innovation Lab in Stockholm.

Former CEO and Investment Director of UniTartu Ventures and Head of Entrepreneurship at the University of Tartu, developing university spinouts and an IP-for-equity investment portfolio.

Board member of Estonian Private Equity & Venture Capital Association (EstVCA) and a certified board member, with experience in corporate governance, investments, and company development.
Holds an MBA from Tallinn University of Technology and a Stanford Graduate School of Business LEAD certificate.

Nordic Science Investments (NSI) is a venture capital firm backing science-based startups in the Nordic and Baltic region. Working closely with universities, researchers and founders, NSI helps turn breakthrough research into businesses with global growth potential. Its focus spans health and life sciences, semiconductors, advanced materials and intelligent systems, combining early-stage capital with hands-on support in company building and commercialisation.